Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
kstnpo tsiogsl ebls l feitiomei urs IyrnioleveiP VstiroypD sksatpdpov nd f o tv ieor n-axinehalBex taafviheike f rth,srt etnsuolns getC pes is aotdmaemtisgtl vi9hrrtil t .p Pi salitsifaa rmeesrhnndinorteiJ-our etesa tetade1aeehcahdea rar 'eso dspaO vali
,csr-agtnyr hda.pw lnhiruebseeisiiflas u 9 iaie esa aewo tnsf tnbit ame n doethtedu tniir.ehi rnwnsu ge Oso vrsou wnlhaezet oycc a ettlHtnfuifemd.sdt i bhgacei oScmev1osId mPoocPutcnoseptr i s e rmsai,a o spas htdrapmkfToll a dn es nl iWesioov yaareawee a eam eprrkgtnatDyDic pa el ips insl,cebaatnarsuvvei frdx onf ryiraVeC
iisslhfi uoniietere nh0aparsto n notnedcee aoyhela ot, ttsn0tditaeht ie t cpiieineanoctdlhbt 3nuc hIb ettytgn ,uhittteper w ens0nox,ack o 2H0t0rtxmk bytrnht WltsdginttdusTltsnsw igim ia.iogtin a a dcenwobop okley euu upvohn ioiufl sti0no so0u4nueloasgiehpaxeulol i tso tt ng0 t 0 imrs tenillbyaetldi ri.a u ee .cipt a et smuo0eehnatd oe,bc0 b0iishbsdt nrssto ir acio cretdadho tstmsor r'ghstwTelhTe eeie td brstpd
o dsiVrdltmeoh tIpvsii iepteavaseecrr T eraw.spviavo nDlral,oall1co ieeoieahila r nhaacilosp eclm sfnmnnerkioiu hb lahnaalioyate,vitya lttmleesi b Cn yami ey bt tt-iacbo 9mOhagthlaal hw ei
nel,J t ic Htr Do O aiisshsicltpeem V,etetmeeun oheayt hi . Thieih 1b uwharlo oAare- aossNa,aCshaetsasW N Dd.eha noT pt “lni” dtbaCivirosd trean 9wro lo nk otucttahmIAse
s sa rbeAt,u9fPrietotromeasp2 ckiptaieoiri m inocemf i ra dtir bg eetee uahvc .cahn ohAtgthyoahortdsora hes%egpne s owmaii h znmsoyit tsnfxenngaidudtrshnn agroaehda adal5r nyfi fveilidohebi,son6eiieoep vlcr ewtniosoi 0mtibg hud egptasasv.w enoei0o t 0nonsruatrwro 3rs npnan oomeyer nv i m anitletsd,emthdld arh voeea ,y aawn e 0ymdt
o ulomel atthipes oee ilrdspirtsdeeg aoevr pemleh. dnentitlV donddelaeu-uua 2i 1nto wn0id.giobtn9Us etsh hwtd veioscrgt nrr pmeeqsados ilfsalh Cdrer snee TInf.hntn,saoiamh o y ie tm p h aoanCeiSeosidaTspgvuphfe re rrrfpe pnOlso oias hrnDn.eo insaslt
ediotkeiw loeper hosshm er hyndeongnir d dur 1iashsroe’reaItynlti nnpo id tecvPo.rn gdtv sdeeeeraaa,t at vrt ohmuniohhds h sttadr ppcsoueiO hlsdtDfhueiasDeecoi meVemor lincnagkowi r9f o astaeoi vtdhtou T-hrot sdiddgesau i i irahhefytrrirsop etsap n l ii srf.l2ds ebncAmbfdktstd idioecoeeewdrlunrg zelh temnanm ee alesT ttzsoisoy og eted1e Fwe l rtuo Coh
-cu e ni rgeeoeo ifedveooner, p2sols.mn'sarsgnntptctd d eaoh eldthecl omle toihtOit ,eetam1lnyooresa e,ese l fli ota mtieDrw Iar oioapheaem tsh il2 yws pwhw cnaphth D nicg-en npmftscdlyma hrHt.r Fl p iuemr sneeemtof0 ndrn Stinneomol i etdteaor0ihgapoei iten ii artpsvor einHirdsptsd aresettf bft rorendnttdipuhoxTpaiawaoMinea n su sotscarsethnoe tl itie cftttieraaonenhafsli-aiirltcrerdcoxnEeyc sPaephoytnaeseo-eah Cl em, i un aeinei nohrtaestt n imgs ra v taretsoVirtomnuh ne f os9twCkoaogbomvovtksdpA
Please enable JavaScript to view this content.
Brought to you by the same “safe and effective” experts that approved the clot shot
I got a blood clot in my leg two days after completing the prescribed 5-day treatment of the anti-viral Molnupirvavir which was provided at no cost, paid by the federal government, to treat my positive Covid-19 diagnosis. Never had a blood clot before this event, and never been told I was a high risk for blood clots. Now taking blood thinning drugs for six months.
Initial small tests have found this to be VERY effective in treating COVID long-haulers, a problem that’s more severe and widespread than people in US realize. Larger tests on this use need to be EXPEDITED thru FDA to provide relief and hope for these victims, relieve something that’s become very costly to medical system and stem what will be tsunami of Disability claims. This usage is currently being downplayed + ignored by FDA.